1
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Usefulness of delivery catheter on accurate right ventricular septal pacing: Mt FUJI trial

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Aims

          Although the delivery catheter system for pacemaker-lead implantation is a new alternative to the stylet system, no randomized controlled trial has addressed the difference in right ventricular (RV) lead placement accuracy to the septum between the stylet and the delivery catheter systems. This multicentre prospective randomized controlled trial aimed to prove the efficacy of the delivery catheter system for accurate delivery of RV lead to the septum.

          Methods and results

          In this trial, 70 patients (mean age 78 ± 11 years; 30 men) with pacemaker indications of atrioventricular block were randomized to the delivery catheter or the stylet groups. Right ventricular lead tip positions were assessed using cardiac computed tomography within 4 weeks of pacemaker implantation. Lead tip positions were classified into RV septum, anterior/posterior edge of the RV septal wall, and RV free wall. The primary endpoint was the success rate of RV lead tip placement to the RV septum.

          Results

          Right ventricular leads were implanted as per allocation in all patients. The delivery catheter group had higher success rate of RV lead deployment to the septum (78 vs. 50%; P = 0.024) and narrower paced QRS width (130 ± 19 vs. 142 ± 15 ms P = 0.004) than those in the stylet group. However, there was no significant difference in procedure time [91 (IQR 68–119) vs. 85 (59–118) min; P = 0.488] or the incidence of RV lead dislodgment (0 vs. 3%; P = 0.486).

          Conclusion

          The delivery catheter system can achieve a higher success rate of RV lead placement to the RV septum and narrower paced QRS width than the stylet system.

          Trial registration number

          jRCTs042200014 ( https://jrct.niph.go.jp/en-latest-detail/jRCTs042200014)

          Graphical Abstract

          Graphical Abstract

          Outcome comparison between delivery catheter and stylet systems. The delivery catheter system can achieve a higher RV lead placement on the RV septum success rate and a narrower paced QRS width than the stylet system. RV, right ventricular.

          Related collections

          Most cited references20

          • Record: found
          • Abstract: found
          • Article: not found

          Adverse effect of ventricular pacing on heart failure and atrial fibrillation among patients with normal baseline QRS duration in a clinical trial of pacemaker therapy for sinus node dysfunction.

          Dual-chamber (DDDR) pacing preserves AV synchrony and may reduce heart failure (HF) and atrial fibrillation (AF) compared with ventricular (VVIR) pacing in sinus node dysfunction (SND). However, DDDR pacing often results in prolonged QRS durations (QRSd) as the result of right ventricular stimulation, and ventricular desynchronization may result. The effect of pacing-induced ventricular desynchronization in patients with normal baseline QRSd is unknown. Baseline QRSd was obtained from 12-lead ECGs before pacemaker implantation in MOST, a 2010-patient, 6-year, randomized trial of DDDR versus VVIR pacing in SND. Cumulative percent ventricular paced (Cum%VP) was determined from stored pacemaker data. Baseline QRSd 40%) and VVIR (HR 2.56 [95% CI, 1.48 to 4.43] for Cum%VP >80%). The risk of AF increased linearly with Cum%VP from 0% to 85% in both groups (DDDR, HR 1.36 [95% CI, 1.09, 1.69]; VVIR, HR 1.21 [95% CI 1.02, 1.43], for each 25% increase in Cum%VP). Model results were unaffected by adjustment for known baseline predictors of HF hospitalization and AF. Ventricular desynchronization imposed by ventricular pacing even when AV synchrony is preserved increases the risk of HF hospitalization and AF in SND with normal baseline QRSd.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: found
            Is Open Access

            Left bundle branch area pacing outcomes: the multicentre European MELOS study  

            Aims Permanent transseptal left bundle branch area pacing (LBBAP) is a promising new pacing method for both bradyarrhythmia and heart failure indications. However, data regarding safety, feasibility and capture type are limited to relatively small, usually single centre studies. In this large multicentre international collaboration, outcomes of LBBAP were evaluated. Methods and results This is a registry-based observational study that included patients in whom LBBAP device implantation was attempted at 14 European centres, for any indication. The study comprised 2533 patients (mean age 73.9 years, female 57.6%, heart failure 27.5%). LBBAP lead implantation success rate for bradyarrhythmia and heart failure indications was 92.4% and 82.2%, respectively. The learning curve was steepest for the initial 110 cases and plateaued after 250 cases. Independent predictors of LBBAP lead implantation failure were heart failure, broad baseline QRS and left ventricular end-diastolic diameter. The predominant LBBAP capture type was left bundle fascicular capture (69.5%), followed by left ventricular septal capture (21.5%) and proximal left bundle branch capture (9%). Capture threshold (0.77 V) and sensing (10.6 mV) were stable during mean follow-up of 6.4 months. The complication rate was 11.7%. Complications specific to the ventricular transseptal route of the pacing lead occurred in 209 patients (8.3%). Conclusions LBBAP is feasible as a primary pacing technique for both bradyarrhythmia and heart failure indications. Success rate in heart failure patients and safety need to be improved. For wider use of LBBAP, randomized trials are necessary to assess clinical outcomes. Structured graphical abstract LBBP, left bundle branch pacing; LBFP, left bundle fascicular pacing; LVSP, left ventricular septal pacing; LBBAP, left bundle branch area pacing; OR, odds ratio.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Effect of right ventricular pacing lead site on left ventricular function in patients with high-grade atrioventricular block: results of the Protect-Pace study.

              Chronic right ventricle (RV) apical (RVA) pacing is standard treatment for an atrioventricular (AV) block but may be deleterious to left ventricle (LV) systolic function. Previous clinical studies of non-apical pacing have produced conflicting results. The aim of this randomized, prospective, international, multicentre trial was to compare change in LV ejection fraction (LVEF) between right ventricular apical and high septal (RVHS) pacing over a 2-year study period.
                Bookmark

                Author and article information

                Contributors
                Journal
                Europace
                Europace
                europace
                Europace
                Oxford University Press (US )
                1099-5129
                1532-2092
                April 2023
                16 February 2023
                16 February 2023
                : 25
                : 4
                : 1451-1457
                Affiliations
                Division of Cardiology, Internal Medicine III, Hamamatsu University School of Medicine , 1-20-1 Handayama, Higashi-ward, Hamamatsu 431-3192, Japan
                Division of Cardiology, Internal Medicine III, Hamamatsu University School of Medicine , 1-20-1 Handayama, Higashi-ward, Hamamatsu 431-3192, Japan
                Department of Cardiology, Chutoen General Medical Center , 1-1 Shobugaike, Kakegawa, 436-0040, Japan
                Department of Cardiology, Chutoen General Medical Center , 1-1 Shobugaike, Kakegawa, 436-0040, Japan
                Department of Cardiology, Chutoen General Medical Center , 1-1 Shobugaike, Kakegawa, 436-0040, Japan
                Department of Cardiology, Juntendo University Shizuoka Hospital , 1129 Nagaoka, Izunokuni, 410-2211, Japan
                Department of Cardiology, Juntendo University Shizuoka Hospital , 1129 Nagaoka, Izunokuni, 410-2211, Japan
                Department of Cardiovascular Medicine, Shizuoka Medical Center , 762-1 Nagasawa, Sunto-gun, 411-8611, Japan
                Department of Cardiovascular Medicine, Shizuoka Medical Center , 762-1 Nagasawa, Sunto-gun, 411-8611, Japan
                Department of Cardiology, Seirei Mikatahara General Hospital , 3453 Mikatahara-cho, Kita-ward, Hamamatsu, 433-8558, Japan
                Department of Cardiology, Seirei Hamamatsu General Hospital , 2-12-1 Sumiyoshi, Naka-ward, Hamamatsu, 430-0906, Japan
                Department of Cardiology, Seirei Hamamatsu General Hospital , 2-12-1 Sumiyoshi, Naka-ward, Hamamatsu, 430-0906, Japan
                Department of Cardiology, Hamamatsu Medical Center , 328 Tomitsuka-cho, Naka-ward, Hamamatsu, 432-8580, Japan
                Department of Cardiology, Hamamatsu Medical Center , 328 Tomitsuka-cho, Naka-ward, Hamamatsu, 432-8580, Japan
                Division of Arrhythmology, Shizuoka Saiseikai General Hospital , 1-1-1 Kojika, Suruga-ward, Shizuoka, 422-8021, Japan
                Department of Cardiology, Kameda Medical Center , 929 Higashi-cho, Kamogawa, 296-8602, Japan
                Division of Cardiology, Internal Medicine III, Hamamatsu University School of Medicine , 1-20-1 Handayama, Higashi-ward, Hamamatsu 431-3192, Japan
                Department of Cardiology, Shintoshi Hospital , 703 Nakaizumi, Iwata, 438-0078, Japan
                Center for Clinical Research, Hamamatsu University Hospital , 1-20-1 Handayama, Higashi-ward, Hamamatsu, 431-3125, Japan
                Center for Clinical Research, Hamamatsu University Hospital , 1-20-1 Handayama, Higashi-ward, Hamamatsu, 431-3125, Japan
                Division of Cardiology, Internal Medicine III, Hamamatsu University School of Medicine , 1-20-1 Handayama, Higashi-ward, Hamamatsu 431-3192, Japan
                Author notes
                Corresponding author. Tel: +81 53 435 2356; fax: +81 53 434 2910. Email address: ynaruse@ 123456hama-med.ac.jp

                Conflict of interest: Dr Yuichiro Maekawa received research and fellowship grants from Biotronik, Medtronic, and Abbott. There is no conflict of interest for the other authors.

                Author information
                https://orcid.org/0000-0001-9630-951X
                https://orcid.org/0000-0003-4638-3257
                https://orcid.org/0000-0003-3051-2624
                https://orcid.org/0000-0003-0007-0650
                https://orcid.org/0000-0002-2193-4000
                https://orcid.org/0000-0003-0869-3078
                https://orcid.org/0000-0003-3731-1075
                https://orcid.org/0000-0001-5999-7747
                https://orcid.org/0000-0002-9801-8035
                https://orcid.org/0000-0001-8623-5940
                https://orcid.org/0000-0001-5365-8752
                https://orcid.org/0000-0001-7802-8511
                https://orcid.org/0000-0001-8193-6617
                https://orcid.org/0000-0002-6677-2965
                https://orcid.org/0000-0002-1970-998X
                Article
                euad027
                10.1093/europace/euad027
                10105868
                36794652
                ff4d4e0a-1b76-4dfe-b2d3-5190224595ee
                © The Author(s) 2023. Published by Oxford University Press on behalf of the European Society of Cardiology.

                This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial License ( https://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@oup.com

                History
                : 31 October 2022
                : 06 January 2023
                Page count
                Pages: 7
                Funding
                Funded by: Medtronic Japan Co., Ltd;
                Award ID: ERP-2019-12060
                Categories
                Clinical Research
                AcademicSubjects/MED00200
                Eurheartj/1
                Eurheartj/4

                Cardiovascular Medicine
                pacemaker,atrioventricular block,right ventricular septal pacing,delivery catheter,stylet

                Comments

                Comment on this article